Purchase Order 36C26322P0970

This federal contract award to Genedx, LLC, doing business as Genedx, supports genetic mutation testing for the National Institutes of Health (NIH) Clinical Center. The $80,477.50 firm fixed-price purchase order has a performance period from July 2018 to July 2018. Genedx, a wholly owned subsidiary of Opko Health, Inc., is a leading provider of genetic testing and diagnostic services, specializing in comprehensive genetic analysis including mutation analysis, exome and genome sequencing, gene...

This firm fixed-price purchase order was awarded by the Office of the Chief Operating Officer (a civilian agency), a component of the National Institutes of Health (NIH), to Genedx, LLC, a for-profit limited liability company. The $81,666 contract is for medical laboratory testing services, specifically genetic testing and diagnostic services. Genedx, a wholly owned subsidiary of Opko Health, Inc., provides comprehensive genetic testing, including mutation analysis, exome and genome...

This is a purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI) to Genedx, LLC, a for-profit limited liability company. The $423,160.00 firm fixed-price contract is for the NHGRI Fellows Training in Clinical Cytogenetics and Biomedical Genome and Genetics program, with a completion date of August 31, 2023. The contract was awarded on August 30, 2018 and does not have a set-aside...

This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute to Genedx, LLC, a subsidiary of Opko Health, Inc. The $25,000.00 firm fixed-price purchase order is for the provision of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing. The contract has a completion date of June 30, 2025. Genedx is the prime...

Genedx, LLC was awarded a $10.5K firm fixed-price call under a Blanket Purchase Agreement (BPA) by the National Cancer Institute for germline mutation testing and variant validation in inherited bone marrow failure syndromes. The contract, awarded on July 12, 2018, with an ultimate completion date of May 22, 2023, represents a specialized procurement supporting the NCI's research and clinical objectives. The work was performed at Genedx's laboratory facilities in Potomac, Maryland. This award...

This is a firm fixed-price purchase order contract awarded by the Office of the Chief Operating Officer at the National Institutes of Health (NIH) to Genedx, LLC, a for-profit limited liability company, for medical laboratory testing services. The contract award, valued at $97,833.65, has a performance period from January 14, 2016, to an ultimate completion date of the same day. Genedx, a wholly owned subsidiary of Opko Health, Inc., is a leading provider of genetic testing and diagnostic...

This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a leading provider of genetic testing and diagnostic services. The contract, valued at $75,395.00, provides for a range of genetic testing services to support NIH research and clinical programs, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing. Genedx, a wholly owned subsidiary of Opko Health, Inc., has extensive...

This firm fixed-price contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Genedx, LLC, a provider of genetic testing and diagnostic services. The $5,250 contract tasks Genedx with providing a range of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing, in support of NIH's clinical research missions. This contract is not set aside for any socioeconomic...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed-price purchase order valued at $11,125 to Genedx, LLC of Montgomery Village, Maryland. This purchase card order is associated with Genedx's existing indefinite-delivery/indefinite-quantity contract with NIH Clinical Center to provide genetic testing services and will be used for monthly invoice payments from September 25, 2023 through September 25, 2023. Genedx, LLC is a wholly owned...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Genedx, LLC, a wholly owned subsidiary of Opko Health, Inc. The contract provides laboratory testing services, including genetic testing and diagnostic services, to support research and clinical programs at the NIH. The contract has a ceiling value of $5,775 and a period of performance through May 22, 2023. The contract was awarded on...